KaloBios Pharmaceuticals Secures $12,000,000 Series D Financing

  • Feed Type
  • Date
  • Company Name
    KaloBios Pharmaceuticals
  • Mailing Address
    260 East Grand Avenue South San Francisco, CA 94080
  • Company Description
    KaloBios is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Genzyme Ventures
  • Venture Investor
    MPM Capital
  • Venture Investor
    Alloy Ventures
  • Venture Investor
    GBS Venture Partners
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    5AM Ventures
  • Venture Investor

Trending on Xconomy